Their subject was the new technology of recombinant DNA — molecules created in a laboratory by stitching together genetic material from different organisms. Researchers were excited by the ...

It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across ... WuXi Biologics' continual ...

It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for ... launching of new technology platforms ...

EffiXTM is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a ...

Genetic technologies have the potential to help solve the ever-growing challenges of food insecurity and global health. But for this potential to be met, regulations that hinder scientific innovation ...

When researchers discover a new technology, its potential isn't always obvious. No one knew at first that email would become ...

Engineered from recombinant DNA, SELPs are copycat proteins inspired by silk and elastin that can be customized for qualities like tensile strength, dye affinity, and elasticity. Silk’s amino ...

The microbial fermentation technology market is experiencing significant growth, fueled by the increasing incidence of chronic diseases like cancer a ...

Eventually, participants hammered out safety protocols for laboratory work with recombinant DNA that went on to influence ...

Marketers have promoted Hawaii’s natural beauty and culture for decades: erupting volcanoes, rainbows, luau, surfing, ...

Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...